Evidence map›Paper›PMID 38439603›Full record

ArticleCurrent protocols2024

Mouse Models of Sepsis.

Shravan Kumar Kannan, Caleb Y Kim, Mohammad Heidarian, Roger R Berton, Isaac J Jensen, Thomas S Griffith, Vladimir P Badovinac

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Current protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Animal Models of Human Disease 2.0.International journal of molecular sciences · 2024
    Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shravan Kumar KannanInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa.
Caleb Y KimMicrobiology, Immunology, and Cancer Biology Program, University of Minnesota, Minneapolis, Minnesota.ORCID https://orcid.org/0000-0003-0093-3049
Mohammad HeidarianDepartment of Pathology, University of Iowa, Iowa City, Iowa.
Roger R BertonInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa.
Isaac J JensenInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa.
Thomas S GriffithMicrobiology, Immunology, and Cancer Biology Program, University of Minnesota, Minneapolis, Minnesota.
Vladimir P BadovinacInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa.ORCID https://orcid.org/0000-0003-3180-2439
University of Iowa · USUniversity of Minnesota · US

Funding

CD4 T cell dysregulation and reprogramming in sepsisR35GM140881 · NIGMS · UNIVERSITY OF MINNESOTA · PI Thomas S Griffith · 2021 to 2026
$2.4M
Cellular and molecular mechanisms controlling sepsis-induced immunoparalyses stateR35GM134880 · NIGMS · UNIVERSITY OF IOWA · PI BADOVINAC, VLADIMIR P · 2020 to 2024
$1.9M
Using microbially-experienced mice to study the innate immune response in sepsisI01BX001324 · VA · MINNEAPOLIS VA MEDICAL CENTER · PI GRIFFITH, THOMAS S · 2013 to 2025
–
BLRD Research Career Scientist Award ApplicationIK6BX006192 · VA · MINNEAPOLIS VA MEDICAL CENTER · PI Thomas S Griffith · 2023 to 2026
–
BLRD VA I01 BX001324BLRD VA IK6 BX006192NIGMS NIH HHS R35 GM134880NIGMS NIH HHS R35 GM140881NIH HHS GM134880NIH HHS GM140881
6 · The paper itself

Abstract

Human sepsis is a complex disease that manifests with a diverse range of phenotypes and inherent variability among individuals, making it hard to develop a comprehensive animal model. Despite this difficulty, numerous models have been developed that capture many key aspects of human sepsis. The robustness of these models is vital for conducting pre-clinical studies to test and develop potential therapeutics. In this article, we describe four different models of murine sepsis that can be used to address different scientific questions relevant to the pathology and immune response during and after a septic event. Basic Protocol 1 details a non-synchronous cecal ligation and puncture (CLP) model of sepsis, where mice are subjected to polymicrobial exposure through surgery at different time points within 2 weeks. This variation in sepsis onset establishes each mouse at a different state of inflammation and cytokine levels that mimics the variability observed in humans when they present in the clinic. This model is ideal for studying the long-term impact of sepsis on the host. Basic Protocol 2 is also a type of polymicrobial sepsis, where injection of a specific amount of cecal slurry from a donor mouse into the peritoneum of recipient mice establishes immediate inflammation and sepsis without any need for surgery. Basic Protocol 3 describes infecting mice with a defined gram-positive or -negative bacterial strain to model a subset of sepsis observed in humans infected with a single pathogen. Basic Protocol 4 describes administering LPS to induce sterile endotoxemia. This form of sepsis is observed in humans exposed to bacterial toxins from the environment. © 2024 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Non-synchronous cecal ligation and puncture Basic Protocol 2: Cecal slurry model of murine sepsis Basic Protocol 3: Monomicrobial model of murine sepsis Basic Protocol 4: LPS model of murine sepsis.

Indexed as

LipopolysaccharidesSepsisAmbulatory Care FacilitiesAnimalsDisease Models, AnimalHumansInflammationMiceLipopolysaccharidescecal slurry sepsisCLPmicrobial sepsismouse modelssepsis

Identifiers

PMID38439603
PMCPMC10917121
OpenAlexW4392469424

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.